Medolife Rx in Discussions with a Major Infomercial Agency and Receives Exceptionally Positive Product Reviews
June 01, 2022 08:00 ET
|
Quanta, Inc.
BURBANK, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biotech company with R&D, manufacturing, and consumer product...
Medolife Rx Announces Results of Comparative Study of Its Flagship CBD-based Muscle Rub and Competitor Products
December 02, 2021 08:00 ET
|
Quanta, Inc.
BURBANK, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product...
Medolife Rx Reports 257% Increase in Efficacy of Ibuprofen Through Proprietary Polarization Method, Looks to Expand Into Other APIs
October 12, 2021 08:30 ET
|
Quanta, Inc.
BURBANK, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product...
Medolife Rx Initiates Comparative Study of Its Flagship CBD-based Muscle Rub and Competitor
October 06, 2021 08:30 ET
|
Quanta, Inc.
BURBANK, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product...
Medolife Rx Files Bi-Annual Report With Ministry of Environment in the Dominican Republic, Details Reservation Expansion and Exceeds Regulatory Expectations
September 29, 2021 08:30 ET
|
Quanta, Inc.
BURBANK, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
Medolife Rx Cancels Optional Reverse Split Previously Included in Filing
July 29, 2021 07:00 ET
|
Quanta, Inc.
BURBANK, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product...
Medolife Rx Announces Donation of Escozine to Heath Clinic in Dominican Republic for Use on Growing COVID-19 Positive Patient Population
July 14, 2021 08:30 ET
|
Quanta, Inc.
BURBANK, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product...
Medolife Rx Clinical Observations Demonstrates Effectiveness of Escozine in Complementary Use with COVID-19 Vaccines
July 08, 2021 08:30 ET
|
Quanta, Inc.
BURBANK, Calif., July 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product...
Medolife Rx Announces Successful Stability Results on Escozine Conjugated With Radioactive Iodine
July 01, 2021 08:30 ET
|
Quanta, Inc.
BURBANK, Calif., July 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product...
Medolife Rx Enters Partnership Agreement with Leading International Distributor, Brings Products to Mexico
June 29, 2021 08:30 ET
|
Quanta, Inc.
BURBANK, Calif., June 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product...